Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander M Menzies

Showing results (1-10 of 282) with videos related to

Pageof 29
Sort By:
The Lancet. Oncology|April 1, 2017
Optimum dosing of ipilimumab in melanoma: too little, too late?Alexander M Menzies, Georgina V Long
Melanoma Management|September 8, 2018
Has the melanoma information tsunami become a maelstrom?John F Thompson, Alexander M Menzies
The Lancet. Oncology|August 1, 2014
Systemic treatment for BRAF-mutant melanoma: where do we go next?Alexander M Menzies, Georgina V Long
Therapeutic Advances in Medical Oncology|September 3, 2013
New combinations and immunotherapies for melanoma: latest evidence and clinical utilityAlexander M Menzies, Georgina V Long
JAMA Oncology|August 26, 2016
Recent Developments in Melanoma TherapyAlexander M Menzies, Georgina V Long
Nature Reviews. Clinical Oncology|April 11, 2023
Combination immunomodulation for immune-checkpoint-inhibitor-associated myocarditisDouglas B Johnson, Alexander M Menzies
Future Oncology (London, England)|June 12, 2025
POLARIS: encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasisAlexander M Menzies, Michael A Davies
European Journal of Cancer (Oxford, England : 1990)|July 23, 2013
Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyondAlexander M Menzies, Georgina V Long
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanomaAlexander M Menzies, Georgina V Long
Internal Medicine Journal|March 19, 2021
Recent advancements in melanoma managementTharani Krishnan, Alexander M Menzies, Rachel Roberts-Thomson
Pageof 29

Showing results (1-10 of 282) with videos related to

Sort By:
Pageof 29
The Lancet. Oncology|April 1, 2017
Optimum dosing of ipilimumab in melanoma: too little, too late?Alexander M Menzies, Georgina V Long
Melanoma Management|September 8, 2018
Has the melanoma information tsunami become a maelstrom?John F Thompson, Alexander M Menzies
The Lancet. Oncology|August 1, 2014
Systemic treatment for BRAF-mutant melanoma: where do we go next?Alexander M Menzies, Georgina V Long
Therapeutic Advances in Medical Oncology|September 3, 2013
New combinations and immunotherapies for melanoma: latest evidence and clinical utilityAlexander M Menzies, Georgina V Long
JAMA Oncology|August 26, 2016
Recent Developments in Melanoma TherapyAlexander M Menzies, Georgina V Long
Nature Reviews. Clinical Oncology|April 11, 2023
Combination immunomodulation for immune-checkpoint-inhibitor-associated myocarditisDouglas B Johnson, Alexander M Menzies
Future Oncology (London, England)|June 12, 2025
POLARIS: encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasisAlexander M Menzies, Michael A Davies
European Journal of Cancer (Oxford, England : 1990)|July 23, 2013
Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyondAlexander M Menzies, Georgina V Long
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanomaAlexander M Menzies, Georgina V Long
Internal Medicine Journal|March 19, 2021
Recent advancements in melanoma managementTharani Krishnan, Alexander M Menzies, Rachel Roberts-Thomson
Pageof 29